Boston Scientific Corporation (BSX)

Market Cap	92.14B -37.1%
Revenue (ttm)	20.07B +19.9%
Net Income	2.90B +56.4%
EPS	1.94 +55.2%
Shares Out	1.49B
PE Ratio	31.96
Forward PE	17.90
Dividend	n/a
Ex-Dividend Date	n/a

Volume	19,486,642
Open	63.72
Previous Close	62.75
Day's Range	61.96 - 64.23
52-Week Range	61.25 - 109.50
Beta	0.78
Analysts	Strong Buy
Price Target	104.48 (+68.52%)
Earnings Date	Apr 22, 2026

About BSX

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatogra...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 18, 1992
• Employees: 59,000
• Stock Exchange: NYSE
• Ticker Symbol: BSX
• Website: https://www.bostonscientific.com

Financial Performance

In 2025, Boston Scientific's revenue was $20.07 billion, an increase of 19.87% compared to the previous year's $16.75 billion. Earnings were $2.90 billion, an increase of 56.40%.

Analyst Summary

According to 21 analysts, the average rating for BSX stock is "Strong Buy." The 12-month stock price target is $104.48, which is an increase of 68.52% from the latest price.

Price Target

$104.48

(68.52% upside)

Analyst Consensus: Strong Buy